Screening for renal disease using serum creatinine: who are we missing?
about
Identifying and slowing progressive chronic renal failureThe costs and benefits of automatic estimated glomerular filtration rate reporting.Randomly and Non-Randomly Missing Renal Function Data in the Strong Heart Study: A Comparison of Imputation MethodsPrevalence of low glomerular filtration rate, proteinuria and associated risk factors in North India using Cockcroft-Gault and Modification of Diet in Renal Disease equation: an observational, cross-sectional study.Renal injury is associated with operative mortality after cardiac surgery for women and men.Validating a case definition for chronic kidney disease using administrative data.Underestimation of impaired kidney function with serum creatinine.Decreased GFR estimated by MDRD or Cockcroft-Gault equation predicts incident CVD: the strong heart study.Subclinical atherosclerotic changes related to chronic kidney disease in asymptomatic black and white young adults: the Bogalusa heart study.Chronic renal insufficiency and renoprotective strategies.Underestimation of chronic renal dysfunction after liver transplantation: ICEBERG study.Natural history of elevated creatinine levelsCompliance with dosing guidelines in patients with chronic kidney disease.Change in appropriate referrals to nephrologists after the introduction of automatic reporting of the estimated glomerular filtration ratePrevalence of chronic kidney disease and its association with risk factors in disadvantageous population.Impact of nucleos(t)ide analogue combination therapy on the estimated glomerular filtration rate in patients with chronic hepatitis BClinical use and pathogenetic basis of laboratory tests for the evaluation of primary arterial hypertension.Case report: adverse drug reactions in unrecognized kidney failure.The implications of the renal NSF for diabetologists.Prevalence of chronic kidney diseases and its determinants among perimenopausal women in a rural area of North India: A community-based study.Chemotherapy practices and perspectives in invasive bladder cancer.High prevalence of stage 3 chronic kidney disease in older adults despite normal serum creatinine.Magnitude of underascertainment of impaired kidney function in older adults with normal serum creatinineCystatin-C is an independent prognostic factor for survival in multiple myeloma and is reduced by bortezomib administration.Impact of occult renal impairment on early and late outcomes following coronary artery bypass graftingNeoadjuvant versus adjuvant chemotherapy for muscle-invasive bladder cancer.Low agreement between the modified diet and renal disease formula and the Cockcroft-Gault formula for assessing chronic kidney disease in cognitively impaired elderly outpatients.Estimating GFR prior to contrast medium examinations--what the radiologist needs to know!Low glomerular filtration rate as an associated risk factor for sarcopenic muscle strength: is creatinine or cystatin C-based estimation more relevant?Preoperative renal function and surgical outcomes in patients with acute type A aortic dissection†.Contrast medium-induced nephropathy. Aspects on incidence, consequences, risk factors and prevention.Effects of dexamethasone on pulmonary and renal functions in patients undergoing CABG with cardiopulmonary bypass.The Chronic Kidney Disease Epidemiology Collaboration cystatin C (CKD-EPI-CysC) equation has an independent prognostic value for overall survival in newly diagnosed patients with symptomatic multiple myeloma; is it time to change from MDRD to CKD-EPA Profile of Renal Function in Northern Cameroonians with Essential Hypertension.Prediction of Major Adverse Cardiovascular and Cerebrovascular Events (MACCE) after Thoracic Surgery- The Role of Estimated GFR.Pharmacokinetics and pharmacodynamics of rocuronium in young adult and elderly patients undergoing elective surgery.A young blood environment decreases aging of senile mice kidneys.Population-specific serum creatinine centiles in neonates with posterior urethral valves already predict long-term renal outcome.Metabolic impact of a soccer match on female players.Female liver transplant recipients with the same GFR as male recipients have lower MELD scores--a systematic bias.
P2860
Q28344781-F7223F7F-8005-49D6-A1D9-71438803C02FQ30437160-527CCDA7-509E-42E9-A95A-D10DCD047598Q30998588-EFD11FD4-38AD-43AE-93B8-CFE82ADFB8F0Q33409781-B3572875-E5B4-45DC-BAB8-F0146192BF40Q33996508-343CB211-A15E-4F87-8AB0-814B726CA30BQ34052928-C293CFD3-AB0E-49B7-A104-D761F0AEB431Q34365143-88EBBE42-6D28-4F92-8520-489075D364EDQ34519960-ECBB0399-3CCD-49BE-945D-28AE4B6DE6AEQ34762649-0B44AAD5-19B2-45E9-9654-878D913F4C3DQ35129832-EB96DE0C-3C87-4660-BBB8-6CF9525F50C9Q35210723-3AE56943-76B9-44BA-8DEF-9D43DE81E9F8Q35612880-17C2E896-2D86-4524-BAF8-81C231938F27Q35726156-5BB8040E-CFDC-4DBA-ABB8-0D457F0A04A6Q35839490-E662F3E3-08A1-4E5F-AF30-51550F72356EQ36104432-26568455-4FC7-45B5-A211-502579190F72Q36151245-0EE17279-1919-4329-8D62-FBD956B8E60BQ36359500-C86183F7-A014-4D89-AF19-7E21DC539ED4Q36406696-F965B881-4AD1-4B33-B1A1-0B6E5BEBC741Q36522010-36437921-5596-4435-BFDF-229CA0B85244Q36612817-175182AF-1130-4046-B727-EFFE2750CC97Q36636656-B6929D2D-7049-48B7-B1CA-B3D4DE58C295Q37024559-95C4181B-1BF1-4EAE-9C8E-1613E78614D3Q37104269-C7BC71B4-BFD0-4EAB-B7A4-258539467DC1Q37112901-402DD2F6-A7B1-45D4-BD7F-D3B81AEA3BEBQ37194189-B42F0BF8-CB2F-4B53-9266-717841C9BBF1Q37508037-FDADB1DF-919F-4770-BAD0-DB2FA9037DA1Q37810410-0D32C5BE-F0AD-4798-860D-2BAF89FB00A4Q38504884-F1481AA1-FA7E-4E08-B035-3B0E04A064B4Q40572760-3755D498-19D5-4ECF-8C7C-7FB5074D9931Q41656192-30C84D5C-25A2-4CB0-873E-E456FE9CA9A0Q41889016-9B5194FF-D2AA-48CB-B369-680E1CABE353Q43233509-3BAA52C9-B8FC-478D-A763-6C6F4EE0198EQ45787936-871A0C7F-0568-4BD6-A3AF-9D5FC374C4BBQ46222134-FE609E50-97A7-480C-9A0A-6E3A01B16D95Q47138165-2AD2BE36-C80D-4311-9E64-89A1B928A74BQ47376616-DAD38DC0-92BC-4FAB-A7B3-210A2741811FQ47639609-E63C5A38-A303-43DE-859D-E6AD0264554EQ50660055-1C2390D4-B047-40D0-9FAD-8F5947A5E4DDQ51435915-AF07E3D8-0758-4E82-A13D-344071EF007CQ51770726-D360568A-70F8-4A3D-A284-C9EE4F41951A
P2860
Screening for renal disease using serum creatinine: who are we missing?
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Screening for renal disease using serum creatinine: who are we missing?
@en
Screening for renal disease using serum creatinine: who are we missing?
@nl
type
label
Screening for renal disease using serum creatinine: who are we missing?
@en
Screening for renal disease using serum creatinine: who are we missing?
@nl
prefLabel
Screening for renal disease using serum creatinine: who are we missing?
@en
Screening for renal disease using serum creatinine: who are we missing?
@nl
P2093
P356
P1476
Screening for renal disease using serum creatinine: who are we missing?
@en
P2093
P304
P356
10.1093/NDT/16.5.1042
P407
P577
2001-05-01T00:00:00Z